Welcome to PSA Rising

powered by
FreeFind Search this site
home | links & resources | cancer headlines always fresh Cancer Newswire | Forums  

WELCOME!

  • Intro: Finding prostate Cancer
  • Biopsy Gleason Partin
  • Hospitals Physicians Pathology Labs
  • Support Groups
  • Prostate Cancer Treatment Guidelines English or Espagñol

Research Tools

  • PubMed
  • Med Dictionary
  • Clinical Trials
  • JournalWatch
Page not found | PSA Rising Prostate Cancer News Skip to content

PSA Rising Prostate Cancer News

PSA Rising Prostate Cancer News

Evidence-Based, Patient-Centered

Primary Menu

  • HOME
  • Prostate Basics
    • The Prostate
    • PSA Test
    • Early Detection Chart
    • MiPS PCa Urine Test
    • Biopsy 1: Is it needed?
  • Living With PCa
    • Exercise & Fitness
  • African-Americans & Prostate Cancer
    • Obesity & PCa “Race Effect”
  • Treatment News
    • Active Surveillance
    • Brachytherapy
    • Radiation Tx Methods
    • Metastatic Castration-Resistant PCa
    • Radium-223
  • BLOG: Advocacy & Opinions
  • FoodNews archive
  • Privacy Policy
PSA Rising Prostate Cancer News

This is somewhat embarrassing, isn’t it?

It seems we can’t find what you’re looking for. Perhaps searching can help.

Recent Posts

  • Biopsy to Detect Prostate Cancer – when is it needed?
  • Prostate Cancer Diagnosis Calls for Early Support So That Men Can Make Smart Treatment Decisions, Study Says
  • Radium-223 linked to longer overall survival in patients with castration-resistant prostate cancer with bone metastases
  • Active Surveillance For Low-Risk Prostate Cancer Does Not Shorten Life
  • Diabetes Risk For Men Treated With Primary Androgen Deprivation for Localized Prostate Cancer

Archives

Try looking in the monthly archives. :)

Tags

Active Surveillance adt adverse effects Alpharadin anatomy anti-osteoporosis drugs Delayed Treatment distress Doppler-guided biopsy DRE Drug Costs Early detection emotions Gleason high risk high risk PCa hpormonal life expectancy low risk PCa MiPS MRI-guided biopsy MYC gene Personalized Care prostate PSA PSA test radiation therapy treatment decision-making TRUS-guided biopsy Urine Test for PCa Watchful Waiting Xofigo

Main Sidebar

Recent Posts

  • Biopsy to Detect Prostate Cancer – when is it needed? June 10, 2015
  • Prostate Cancer Diagnosis Calls for Early Support So That Men Can Make Smart Treatment Decisions, Study Says June 9, 2015
  • Radium-223 linked to longer overall survival in patients with castration-resistant prostate cancer with bone metastases June 3, 2015
  • Active Surveillance For Low-Risk Prostate Cancer Does Not Shorten Life June 2, 2015

Prostate Basics

  • The Prostate
  • PSA Test
  • Early Detection Chart
  • Urine Test for PCa
  • Biopsy 1: When is it Needed?

RSS Recent Blog Posts

  • Blood Simple – Pathologist Michael Misialek encourages men’s health checkups as the PSA era heads toward Gene Tests and the Prostate Health Index June 11, 2015
  • Wear Plaid for Dad, Eh? May 25, 2015
  • Zytiga Lowers PSA in men with high-risk prostate cancer, at a cost in side-effects May 24, 2015

Footer Content

&copy PSA Rising 2015 All Rights Reserved. General Disclaimer PSA Rising is designed for informational purposes only and is not engaged in rendering medical advice or professional services. News and information provided via PSA Rising are not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care providers.
• Using Tiny Framework • Log in

Greater Risk of Developing Prostate Cancer When A Brother Has the Disease, Risk Increased Nearly Three-Fold

PHILADELPHIA (Sept. 12, 2003) -- It has been well-established that the risk of prostate cancer is increased among men who have a first-degree relative (father, son, brother) with the disease, but new research shows the risk is greatly increased for men who have a brother with prostate cancer.At team led by Deborah Watkins Bruner, Ph.D., at Fox Chase Cancer Center in Philadelphia, Pa., published a study online riday, Sept. 12, 2003, in the International Journal of Cancer that shows this is the case.

"This study is the first to report a statistically higher risk associated with having a brother with prostate cancer than having an affected father," said Bruner. Bruner, director of the Prostate Cancer Risk Assessment Program at Fox Chase, and her colleagues conducted a systematic review and meta-analysis of the current literature, using 23 of 332 published studies that met meticulous criteria.

The results confirmed an increased risk of prostate cancer for men with a family history of the disease, but the meta-analysis revealed a 2.9 fold increased risk when the affected relative was a brother. The risk increased 1.8 fold when the affected relative was a second-degree family member (a grandfather or uncle), and 2.1 fold when the relative with prostate cancer was a father.

"Unlike the maternal-child pattern that we see with inherited breast cancers, a brother with prostate cancer was associated with a significantly increased risk of the disease compared to a father or any other relative with the disease," explained Bruner. "This may suggest that the risk may be related to shared environmental factors such as dietary exposures or age of onset of disease, which might reveal a stronger genetic risk."

Bruner said this is another crucial step to better identify who is at risk of developing prostate cancer. "The ultimate goal is to reduce unnecessary screenings and biopsies by identifying at-risk populations and better tailor prostate cancer screening for those men."

Bruner concluded by saying more research into patterns of inherited prostate cancer risk is needed. "We need to assess the risk of disease associated with younger age [less than 65 or 70 years] of onset, dietary habits and lifestyle behaviors that may interact with inherited genes to increase prostate cancer risk." SOURCE: Fox Chase. Ed. J Strax.

Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at www.fccc.edu.

Article: " Risk of Prostate Cancer for Men with Affected Relatives: Systematic Review and Meta-Analysis." Deborah Watkins Bruner, Ph.D., Dirk Moore, Ph.D., Alicia Parlanti, M.S., Joanne Dorgan, Ph.D., Paul Engstrom, M.D.; International Journal of Cancer. www3.interscience.wiley.com/cgi-bin/jissue/76502439

This page made and last edited by J.Strax, Jan 2004.

Importance of Testing PSA Levels During First Months After Radiotherapy: Texas Report Oct 6 2003

Bostwick Laboratories Announces uPM3(TM) Test, First Genetic Test for Prostate Cancer (PSA Rising, Oct 10 20003)

"Complexed" PSA Test (cPSA) More Accurate than Tradional PSA Test Oct 11, 2003

Study Confirms PSA Test Reduces Prostate Cancer Deaths in Blacks and Whites National Cancer Institute August 30, 2003
Advertisements

New from Dr. Strum

A Primer on Prostate Cancer: The Empowered Patient's Guide by Stephen Strum, MD & Donna Pogliano $28.95 Paperback

cover
Prostate Cancer for Dummies by Paul H. Lange (Author), Christine Adamec
List Price: $21.99 Price: $8.80. You save $13.19 (60%)


We subscribe to the HONcode principles.
Verify here.

Wear blue Prostate Cancer Awareness ribbon! About Us | Site Archive | Content Policy/Disclaimer | Privacy Policy © 1997-2004 PSA Rising